BARBARA BIEMANS,WOLFGANG GUBA,GEORG JAESCHKE,LOTHAR LINDEMANN,FIONN O,HARA,ANTONIO RICCI,DANIEL RUEHER,ERIC VIEIRA
申请号：
PT16739442
公开号：
PT3322701T
申请日:
2016.07.11
申请国别(地区):
PT
年份:
2019
代理人:
摘要：
The present invention relates to positive allosteric modulators (PAMs) of metabotropic glutamate receptor 4 (mGluR4) that may be used for the treatment of conditions such as Parkinson's disease, anxiety, emesis, obsessive compulsive disorder, autism, neuroprotection, cancer, depression and diabetes type 2.
